arrow
F

Filiz Öezkan

West German Cancer Center
H指数:12
被引数:712

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Subclinical pulmonary embolism in first-line/induction therapy of lung cancer - a remaining clinically relevant adverse event

肺癌一线/诱导治疗中的亚临床肺栓塞 - 一个持续存在的临床相关不良事件

2026-09-220
OAAI
Early Years, Advanced Disease: The Unmet Need in Young Adults with Non-Small Cell Lung Cancer

早年,晚期疾病:非小细胞肺癌年轻成年患者中的未满足需求

2025-09-240
OAAI
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
2024-08-281
OAAI
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (vol 28, 2155, 2022)
2023-10-100
OAAI
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

68Ga-SSO-120 PET用于小细胞肺癌患者初始分期的单中心回顾性研究

2023-07-205
OA
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
2022-09-12133
OAAI
DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
2021-04-0121
PREAI